Oral Cancer Chemotherapy Adherence and Adherence Assessment Tools: a Report from North Central Cancer Group Trial N0747 and a Systematic Review of the Literature

@article{Patel2013OralCC,
  title={Oral Cancer Chemotherapy Adherence and Adherence Assessment Tools: a Report from North Central Cancer Group Trial N0747 and a Systematic Review of the Literature},
  author={Krishna C. Patel and Nathan R. Foster and Ann Farrell and Nguyet Anh Le-Lindqwister and Josy Mathew and Brian Costello and John Reynolds and Jeffrey P. Meyers and Aminah Jatoi},
  journal={Journal of Cancer Education},
  year={2013},
  volume={28},
  pages={770-776}
}
Oncologists are now prescribing more oral chemotherapy than ever before, thus placing the onus for taking the right dose at the right time under the right circumstances directly on the patient. This study was undertaken to understand emerging adherence issues and to explore available adherence assessment tools. This two-part study (1) examined N0747, a randomized phase II trial that tested the oral agents, sunitinib and capecitabine, in patients with metastatic esophageal cancer from an… CONTINUE READING